bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride

C103H143Cl2N15O11 — CID 158387751

IUPACbis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride
SMILESCN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCN(Cc4ccc[nH]c4=O)CC3)noc12.CN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCN(Cc4ccc[nH]c4=O)CC3)noc12.CN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCNCC3)noc12.COc1ncccc1CN1CCC(CCc2noc3c(CN(C)C)c(OCC4CC4)ccc23)CC1.Cl.Cl
InChIInChI=1S/C28H38N4O3.2C27H36N4O3.C21H31N3O2.2ClH/c1-31(2)18-24-26(34-19-21-6-7-21)11-9-23-25(30-35-27(23)24)10-8-20-12-15-32(16-13-20)17-22-5-4-14-29-28(22)33-3;2*1-30(2)17-23-25(33-18-20-5-6-20)10-8-22-24(29-34-26(22)23)9-7-19-11-14-31(15-12-19)16-21-4-3-13-28-27(21)32;1-24(2)13-18-20(25-14-16-3-4-16)8-6-17-19(23-26-21(17)18)7-5-15-9-11-22-12-10-15;;/h4-5,9,11,14,20-21H,6-8,10,12-13,15-19H2,1-3H3;2*3-4,8,10,13,19-20H,5-7,9,11-12,14-18H2,1-2H3,(H,28,32);6,8,15-16,22H,3-5,7,9-14H2,1-2H3;2*1H
InChIKeyMJVYANYQLFANFI-UHFFFAOYSA-N
MW1838.28 g/mol
LogP17.80
Rot. Bonds39

About bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride

bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride (PubChem CID 158387751) has the molecular formula C103H143Cl2N15O11 and a molecular weight of 1838.28 g/mol. Its IUPAC name is bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride.

Molecular Properties

Compound Namebis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride
PubChem CID158387751
Molecular FormulaC103H143Cl2N15O11
Molecular Weight1838.28 g/mol
Exact Mass1836.05
IUPAC Namebis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride
SMILESCN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCN(Cc4ccc[nH]c4=O)CC3)noc12.CN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCN(Cc4ccc[nH]c4=O)CC3)noc12.CN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCNCC3)noc12.COc1ncccc1CN1CCC(CCc2noc3c(CN(C)C)c(OCC4CC4)ccc23)CC1.Cl.Cl
InChIInChI=1S/C28H38N4O3.2C27H36N4O3.C21H31N3O2.2ClH/c1-31(2)18-24-26(34-19-21-6-7-21)11-9-23-25(30-35-27(23)24)10-8-20-12-15-32(16-13-20)17-22-5-4-14-29-28(22)33-3;2*1-30(2)17-23-25(33-18-20-5-6-20)10-8-22-24(29-34-26(22)23)9-7-19-11-14-31(15-12-19)16-21-4-3-13-28-27(21)32;1-24(2)13-18-20(25-14-16-3-4-16)8-6-17-19(23-26-21(17)18)7-5-15-9-11-22-12-10-15;;/h4-5,9,11,14,20-21H,6-8,10,12-13,15-19H2,1-3H3;2*3-4,8,10,13,19-20H,5-7,9,11-12,14-18H2,1-2H3,(H,28,32);6,8,15-16,22H,3-5,7,9-14H2,1-2H3;2*1H
InChIKeyMJVYANYQLFANFI-UHFFFAOYSA-N
XLogP17.80
TPSA263.59 Ų
H-Bond Donors3
H-Bond Acceptors24
Rotatable Bonds39
Heavy Atoms131
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001838.28
LogP ≤ 517.80
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1024

Analyze bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride?
The IUPAC name of bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride (CID 158387751) is bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride.
What is the SMILES notation for bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride?
The canonical SMILES for bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride is CN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCN(Cc4ccc[nH]c4=O)CC3)noc12.CN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCN(Cc4ccc[nH]c4=O)CC3)noc12.CN(C)Cc1c(OCC2CC2)ccc2c(CCC3CCNCC3)noc12.COc1ncccc1CN1CCC(CCc2noc3c(CN(C)C)c(OCC4CC4)ccc23)CC1.Cl.Cl.
What is the InChIKey of bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride?
The InChIKey is MJVYANYQLFANFI-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H38N4O3.2C27H36N4O3.C21H31N3O2.2ClH/c1-31(2)18-24-26(34-19-21-6-7-21)11-9-23-25(30-35-27(23)24)10-8-20-12-15-32(16-13-20)17-22-5-4-14-29-28(22)33-3;2*1-30(2)17-23-25(33-18-20-5-6-20)10-8-22-24(29-34-26(22)23)9-7-19-11-14-31(15-12-19)16-21-4-3-13-28-27(21)32;1-24(2)13-18-20(25-14-16-3-4-16)8-6-17-19(23-26-21(17)18)7-5-15-9-11-22-12-10-15;;/h4-5,9,11,14,20-21H,6-8,10,12-13,15-19H2,1-3H3;2*3-4,8,10,13,19-20H,5-7,9,11-12,14-18H2,1-2H3,(H,28,32);6,8,15-16,22H,3-5,7,9-14H2,1-2H3;2*1H.
What are the key properties of bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride?
bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride has a molecular weight of 1838.28 g/mol, XLogP of 17.80, 39 rotatable bonds, 3 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for bis(3-[[4-[2-[6-(cyclopropylmethoxy)-7-[(dimethylamino)methyl]-1,2-benzoxazol-3-yl]ethyl]piperidin-1-yl]methyl]-1H-pyridin-2-one);1-[6-(cyclopropylmethoxy)-3-[2-[1-[(2-methoxy-3-pyridinyl)methyl]piperidin-4-yl]ethyl]-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;1-[6-(cyclopropylmethoxy)-3-(2-piperidin-4-ylethyl)-1,2-benzoxazol-7-yl]-N,N-dimethylmethanamine;dihydrochloride is sourced from PubChem (CID 158387751), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).